Prognostic Factors for Treatment Failure of Photodynamic Therapy and 5-Fluorouracil in Bowen's Disease
- Shima Ahmady 1,2, Patty J Nelemans 3, Myrurgia Abdul Hamid 4, Thomas B J Demeyere 5, Arienne M W van Marion 6, Nicole W J Kelleners-Smeets 1,2, Klara Mosterd 1,2
- Shima Ahmady 1,2, Patty J Nelemans 3, Myrurgia Abdul Hamid 4
- 1Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.
- 2GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.
- 3Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.
- 4Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
- 5Eurofins Pathology and Medical Microbiology (PAMM), Eindhoven, The Netherlands.
- 6Department of Pathology, VieCuri Medical Center, Venlo, The Netherlands.
- 0Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Clinical lesion diameter is the key factor predicting treatment success for Bowen's disease using non-invasive methods like 5-fluorouracil or photodynamic therapy. Larger lesions (>10 mm) show a higher risk of treatment failure.
Area Of Science
- Dermatology
- Oncology
- Clinical Research
Background
- Prognostic factors for non-invasive treatment of Bowen's disease remain largely unknown.
- Identifying factors predicting treatment failure is crucial for optimizing patient outcomes.
- This study investigated lesion characteristics influencing treatment response.
Purpose Of The Study
- To identify patient and lesion characteristics associated with treatment failure in Bowen's disease.
- To evaluate the prognostic value of lesion thickness and hair follicle extension.
- To determine predictors of treatment failure after 5-fluorouracil and photodynamic therapy.
Main Methods
- A randomized trial involving 169 patients with Bowen's disease treated with 5-fluorouracil or photodynamic therapy.
- Re-examination of biopsy specimens to measure lesion thickness and hair follicle extension.
- Logistic regression analysis to assess risk factors for treatment failure at 1-year follow-up.
Main Results
- Lesion thickness and hair follicle involvement were not significantly associated with treatment failure.
- Clinical lesion diameter was the sole significant predictor of 1-year treatment failure (OR = 1.08 per mm).
- Lesions >10 mm had a 23.4% failure rate compared to 10.3% for lesions ≤10 mm.
Conclusions
- Clinical lesion diameter is the primary prognostic factor for non-invasive treatment response in Bowen's disease.
- Lesion size should be considered when selecting treatment and counseling patients.
- Further research may explore other potential predictive markers.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

